Alshamleh, Islam
Kurrle, Nina http://orcid.org/0000-0003-0290-1489
Makowka, Philipp http://orcid.org/0000-0002-4270-831X
Bhayadia, Raj http://orcid.org/0000-0003-0865-9582
Kumar, Rahul
Süsser, Sebastian
Seibert, Marcel
Ludig, Damian http://orcid.org/0000-0002-0042-6322
Wolf, Sebastian
Koschade, Sebastian E. http://orcid.org/0000-0001-5770-1279
Stoschek, Karoline
Kreitz, Johanna
Fuhrmann, Dominik C.
Toenges, Rosa
Notaro, Marco
Comoglio, Federico
Schuringa, Jan Jacob
Berg, Tobias http://orcid.org/0000-0003-2668-0449
Brüne, Bernhard http://orcid.org/0000-0001-8237-2841
Krause, Daniela S. http://orcid.org/0000-0003-3603-1119
Klusmann, Jan-Henning http://orcid.org/0000-0002-1070-0727
Oellerich, Thomas http://orcid.org/0000-0001-6570-6125
Schnütgen, Frank http://orcid.org/0000-0002-2426-6685
Schwalbe, Harald
Serve, Hubert http://orcid.org/0000-0001-8472-5516
Funding for this research was provided by:
Else Kröner-Fresenius-Stiftung
Dr. Mildred Scheel Stiftung für Krebsforschung
Article History
Received: 8 March 2021
Revised: 18 August 2023
Accepted: 14 September 2023
First Online: 7 November 2023
Competing interests
: JHK has advisory roles for Bluebird Bio, Boehringer Ingelheim, Novartis, Roche and Jazz Pharmaceuticals. FC is a founder and partner of enGene Statistics GmbH. The remaining authors declare no conflict of interests.